D.E. Shaw & Co’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.24M Sell
7,186
-13,340
-65% -$2.3M ﹤0.01% 2125
2025
Q1
$3.2M Sell
20,526
-17,454
-46% -$2.72M ﹤0.01% 1592
2024
Q4
$5.23M Sell
37,980
-52,400
-58% -$7.21M ﹤0.01% 1284
2024
Q3
$13.5M Sell
90,380
-191,157
-68% -$28.5M 0.01% 820
2024
Q2
$38.4M Sell
281,537
-58,581
-17% -$7.99M 0.04% 343
2024
Q1
$51.4M Buy
340,118
+74,961
+28% +$11.3M 0.04% 298
2023
Q4
$33.4M Buy
265,157
+44,604
+20% +$5.62M 0.03% 371
2023
Q3
$20.7M Buy
220,553
+88,470
+67% +$8.28M 0.02% 534
2023
Q2
$11.8M Sell
132,083
-7,133
-5% -$637K 0.01% 796
2023
Q1
$14.9M Buy
139,216
+22,512
+19% +$2.41M 0.02% 727
2022
Q4
$14.3M Buy
116,704
+24,894
+27% +$3.04M 0.02% 758
2022
Q3
$9.48M Sell
91,810
-7,972
-8% -$823K 0.01% 932
2022
Q2
$9.28M Sell
99,782
-52,177
-34% -$4.85M 0.01% 1038
2022
Q1
$17.8M Sell
151,959
-2,661
-2% -$312K 0.02% 760
2021
Q4
$20.8M Buy
154,620
+129,793
+523% +$17.5M 0.02% 689
2021
Q3
$3.96M Buy
24,827
+18,710
+306% +$2.98M ﹤0.01% 1636
2021
Q2
$805K Sell
6,117
-2,250
-27% -$296K ﹤0.01% 2643
2021
Q1
$1.08M Sell
8,367
-14,241
-63% -$1.83M ﹤0.01% 2143
2020
Q4
$3.77M Buy
22,608
+6,243
+38% +$1.04M ﹤0.01% 1445
2020
Q3
$2.53M Sell
16,365
-3,781
-19% -$583K ﹤0.01% 1524
2020
Q2
$2.98M Buy
20,146
+147
+0.7% +$21.7K ﹤0.01% 1420
2020
Q1
$2.25M Buy
19,999
+17,750
+789% +$2M ﹤0.01% 1453
2019
Q4
$313K Sell
2,249
-12,573
-85% -$1.75M ﹤0.01% 2348
2019
Q3
$1.43M Sell
14,822
-2,163
-13% -$208K ﹤0.01% 1710
2019
Q2
$1.96M Sell
16,985
-241,192
-93% -$27.8M ﹤0.01% 1621
2019
Q1
$30.4M Buy
258,177
+211,996
+459% +$25M 0.04% 419
2018
Q4
$2.89M Buy
46,181
+5,881
+15% +$368K ﹤0.01% 1349
2018
Q3
$2.86M Buy
40,300
+20,377
+102% +$1.44M ﹤0.01% 1378
2018
Q2
$1.33M Buy
19,923
+14,381
+259% +$956K ﹤0.01% 1778
2018
Q1
$362K Buy
+5,542
New +$362K ﹤0.01% 2178